Marco A. S. Baptista

Medicine · Health Sciences

24h-index4.0kcitations48works0.32yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Parkinson's Disease Mechanisms and Treatments(24), Neuroscience and Neuropharmacology Research(6), Neurotransmitter Receptor Influence on Behavior(5), Alzheimer's disease research and treatments(5), Cellular transport and secretion(5)

Publications48 total

PRECLINICAL EVALUATION OF A MRGX2 TARGETING CYTAC FOR DEPLETING TISSUE-RESIDENT MAST CELLS 8224
Annals of Allergy Asthma & Immunology·2025
The effect of LRRK2 loss-of-function variants in humans
UNC Libraries·2025Open Access
Author Correction: The effect of LRRK2 loss-of-function variants in humans
UNC Libraries·2025Open Access
Lessons Learned and Recommendations from a SCOPE Spinal Cord Injury Neurorestorative Clinical Trials Update
Neurotrauma Reports·2025· 1 citedOpen Access
Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2022 Update
Journal of Parkinson s Disease·2022· 116 citedOpen Access
Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2021 Update
Journal of Parkinson s Disease·2021· 78 citedOpen Access
Author Correction: The effect of LRRK2 loss-of-function variants in humans
Nature Medicine·2021Open Access
Contributors
Elsevier eBooks·2020
Parkinson's disease: Genetic-driven therapeutic approaches
Elsevier eBooks·2020
The Michael J. Fox Foundation’s Strategies for Accelerating Translation of LRRK2 into Therapies for Parkinson Disease
Cells·2020· 6 citedOpen Access
Elevated In Vitro Kinase Activity in Peripheral Blood Mononuclear Cells of <scp>Leucine‐Rich</scp> Repeat Kinase 2 <scp>G2019S</scp> Carriers: A Novel <scp>Enzyme‐Linked</scp> Immunosorbent Assay–Based Method
Movement Disorders·2020· 32 citedOpen Access
The effect of LRRK2 loss-of-function variants in humans
Nature Medicine·2020· 108 citedOpen Access
LRRK2 inhibitors induce reversible changes in nonhuman primate lungs without measurable pulmonary deficits
Science Translational Medicine·2020· 125 cited
Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation
Journal of Visualized Experiments·2020· 6 cited
Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation
Journal of Visualized Experiments·2020· 11 citedOpen Access
An Assessment of LRRK2 Serine 935 Phosphorylation in Human Peripheral Blood Mononuclear Cells in Idiopathic Parkinson’s Disease and G2019S LRRK2 Cohorts
Journal of Parkinson s Disease·2020· 48 citedOpen Access
Higher Urine bis(Monoacylglycerol)Phosphate Levels in LRRK2 G2019S Mutation Carriers: Implications for Therapeutic Development
Movement Disorders·2019· 81 citedOpen Access
An assessment of LRRK2 serine 935 phosphorylation in human peripheral blood mononuclear cells in idiopathic Parkinson’s disease and G2019S <i>LRRK2</i> cohorts
2019· 2 citedOpen Access
The Michael J. Fox Foundation for Parkinson’s Research Strategy to Advance Therapeutic Development of PINK1 and Parkin
Biomolecules·2019· 25 citedOpen Access
Human loss-of-function variants suggest that partial LRRK2 inhibition is a safe therapeutic strategy for Parkinson’s disease
2019· 16 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Brian Fiske(12), Todd Sherer(7), Irina M. Armean(6), Beryl B. Cummings(6), Kristen M. Laricchia(6), Juliana C.N. Chan(6), Shalini Padmanabhan(6), Francesca Tonelli(5), Matthew Fell(5), Dario R. Alessi(5), Kalpana Merchant(5), Nicola Whiffin(5), Aaron Kleinman(5), Jamie L. Marshall(5), Eric Vallabh Minikel(5), Qingbo S. Wang(5), Konrad J. Karczewski(5), Laurent C. Francioli(5), Anna Guan(5), Babak Alipanahi(5)